Incidence of Ipilimumab-Related Serious Adverse Events in Patients with Advanced Cancer: A Meta-Analysis

Background: Little is known about the incidence of ipilimumab-related serious adverse events (SAEs) across various tumor types, drug doses and treatment regimens. Methods: PubMed database was searched up to November, 2017 to identify prospective clinical trials of ipilimumab therapy for adult patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Chang-Ying, Jiang, Si-Cong, Kuang, Yu-Kang, Hu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329845/
https://www.ncbi.nlm.nih.gov/pubmed/30662532
http://dx.doi.org/10.7150/jca.28120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329845/
https://www.ncbi.nlm.nih.gov/pubmed/30662532
http://dx.doi.org/10.7150/jca.28120

Ejemplares similares